Mozart Therapeutics
PrivateLast Round
Series A
Extension
Jun 7, 2023
Total Funding Raised
$80M
Momentum Score
25 /100
Company Overview
Mozart Therapeutics is a biotechnology company specializing in the development of innovative immune engagers and CD8 T-cell immune modulators for the treatment of autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mozart Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Mozart Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 7, 2023 | ||||
| Series A | Oct 26, 2021 |
Mozart Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MRL Ventures Fund | Series A, Series A Extension |
| MRLV | Series A, Series A Extension |
| Altitude Life Science Ventures | Series A, Series A Extension |
| ARCH Venture Partners | Series A Extension, Series A, Seed |
| AbbVie Ventures | Series A Extension |
| Alexandria Venture Investments | Series A, Series A Extension |
| Pfizer Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Presented interim Phase Ib results at the Immunology of Diabetes Society Congress.
- Apr 23, 2026
Positive interim Phase Ib results for MTX-101 in type 1 diabetes patients.
Mozart Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mozart Therapeutics's valuation, stock price, and market status.
